CTRI/2017/01/007733已完成2 期
A randomized, double blind, sham controlled study of transcranial direct current stimulation (tDCS) as an augmentation intervention for the attenuation of motor deficits in patients with arterial stroke. - STDCS
Dr Chittaranjan Andrade0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Occurrence of first, ischemic or hemorrhagic, supratentorial stroke with focal motor deficits
- •2 Premorbid Modified Rankin Scale is less than 3
排除标准
- •1 Presence of global aphasia
- •2 Major unstable co-morbidity, including medical and neuropsychiatric co morbidity (e.g. delirium, depression, recent myocardial infarction, unstable angina etc)
- •3 Past or current history of major neuropsychiatric illnesses e.g., Alzheimerâ??s disease, Parkinsonâ??s disease, Epilepsy, Schizophrenia, Bipolar disorder, Major Depressive Disorder
- •3 Current or recent (less than 3 months) use of psychotropic medication such as antidepressants, antipsychotics and anticonvulsant drugs for more than 7 consecutive dayy. Anxiolytic and hypnotic medications are however permitted.
- •4 Inability to perform study procedures because of uncorrected visual impairment or uncorrected hearing impairment.
- •5 Presence of cerebral or cardiovascular implants.
- •6 Electroconvulsive therapy, repetitive transcranial magnetic stimulation, or any other brain stimulation therapy in the last six months
研究者
相似试验
已完成
不适用
A randomized, double-blind, sham-controlled study of static electric field therapy by high voltage alternating current for active rheumatoid arthritisa randomized, double-blinded, sham-controlled trialJPRN-UMIN000009442Toshikazu Yoshikawa40
已完成
不适用
A double-blind, randomized, sham-controlled study for efficacy and safety of digital therapeutics of the Sleep Index based cognitive Behavioral Therapy for Insomnia : dSIBT-I studyKCT0007823Asan Medical Center50
进行中（未招募）
1 期
Safety and efficacy of Intrathecal OAV101 in Pediatric Patients with Spinal Muscular Atrophy (SMA) (STEER)Spinal Muscular AtrophyEUCTR2021-003474-31-GRovartis Pharma AG125
进行中（未招募）
3 期
Randomized, placebo-controlled, double-blind trial of intrathecal (IT) OAV101 administration in patients with later onset Type 2 spinal muscular atrophy (SMA), to evaluate the efficacy and safety.CTRI/2021/11/037956ovartis Healthcare Pvt Ltd
进行中（未招募）
1 期
Safety and efficacy of Intrathecal OAV101 in Pediatric Patients with Spinal Muscular Atrophy (SMA) (STEER)MedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersSpinal Muscular AtrophyEUCTR2021-003474-31-DKovartis Pharma AG125